Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 2006
Gene Symbol: ELN
ELN
0.060 Biomarker phenotype BEFREE <b>Conclusion:</b> Chronic nicotine exposure induces aortic MMP expression and structural aortic damage (elastin fragmentation), irreversibly increasing aortic stiffness. 30429794 2018
Entrez Id: 6462
Gene Symbol: SHBG
SHBG
0.020 Biomarker phenotype BEFREE Aortic stiffness and central SBP are independently associated with orthostatic SBP fall in CKD patients. 31598911 2019
Entrez Id: 54535
Gene Symbol: CCHCR1
CCHCR1
0.020 Biomarker phenotype BEFREE Aortic stiffness and central SBP are independently associated with orthostatic SBP fall in CKD patients. 31598911 2019
Entrez Id: 8991
Gene Symbol: SELENBP1
SELENBP1
0.020 Biomarker phenotype BEFREE Aortic stiffness and central SBP are independently associated with orthostatic SBP fall in CKD patients. 31598911 2019
Entrez Id: 185
Gene Symbol: AGTR1
AGTR1
0.080 GeneticVariation phenotype BEFREE Angiotensin II type 1 receptor-153A/G and 1166A/C gene polymorphisms and increase in aortic stiffness with age in hypertensive subjects. 11288810 2001
Entrez Id: 2200
Gene Symbol: FBN1
FBN1
0.040 GeneticVariation phenotype BEFREE Fibrillin-1 genotype is associated with aortic stiffness and disease severity in patients with coronary artery disease. 11854120 2002
Entrez Id: 185
Gene Symbol: AGTR1
AGTR1
0.080 GeneticVariation phenotype BEFREE Angiotensin II type 1 receptor (AGT1R) gene 1166A > C polymorphism has been shown to be associated with essential hypertension and aortic stiffness as measured by carotid femoral pulse wave velocity (PWV). 17227479 2007
Entrez Id: 2200
Gene Symbol: FBN1
FBN1
0.040 GeneticVariation phenotype BEFREE Fibrillin-1 (FBN1) is an important constituent of the vascular wall and earlier studies have indicated an effect of the FBN1 2/3 genotype on blood pressure as well as aortic stiffness in men. 24837032 2014
Entrez Id: 1636
Gene Symbol: ACE
ACE
0.040 GeneticVariation phenotype BEFREE A polymorphism in the angiotensin-converting-enzyme gene (ACE I/D) has been associated with abdominal aortic aneurysm and a link between aortic aneurysm and aortic stiffness has been suggested. 21570325 2011
Entrez Id: 50964
Gene Symbol: SOST
SOST
0.010 Biomarker phenotype BEFREE After adjusting for confounders, serum sclerostin [odds ratio = 1.005 (1.002-1.007), p = 0.002] levels remained an independent predictor of aortic stiffness. 30547685 2019
Entrez Id: 5972
Gene Symbol: REN
REN
0.020 GeneticVariation phenotype BEFREE After adjustments for baseline albuminuria and renal function, age, sex, diabetes duration and use of renin-angiotensin antagonists, poorer control of blood glucose (HR 1.17; 95% CI 0.98, 1.40; p = 0.09 for each 1 SD increment in mean first-year HbA<sub>1c</sub>), higher ambulatory systolic BP (HR 1.28; 95% CI 1.09, 1.50; p = 0.003, for each 1 SD increase in daytime systolic BP [SBP]) and increased aortic stiffness (HR 1.16; 95% CI 1.00, 1.34; p = 0.05) were independent predictors of development or progression of DKD. 29063128 2018
Entrez Id: 8991
Gene Symbol: SELENBP1
SELENBP1
0.020 Biomarker phenotype BEFREE After adjustments for baseline albuminuria and renal function, age, sex, diabetes duration and use of renin-angiotensin antagonists, poorer control of blood glucose (HR 1.17; 95% CI 0.98, 1.40; p = 0.09 for each 1 SD increment in mean first-year HbA<sub>1c</sub>), higher ambulatory systolic BP (HR 1.28; 95% CI 1.09, 1.50; p = 0.003, for each 1 SD increase in daytime systolic BP [SBP]) and increased aortic stiffness (HR 1.16; 95% CI 1.00, 1.34; p = 0.05) were independent predictors of development or progression of DKD. 29063128 2018
Entrez Id: 6462
Gene Symbol: SHBG
SHBG
0.020 Biomarker phenotype BEFREE After adjustments for baseline albuminuria and renal function, age, sex, diabetes duration and use of renin-angiotensin antagonists, poorer control of blood glucose (HR 1.17; 95% CI 0.98, 1.40; p = 0.09 for each 1 SD increment in mean first-year HbA<sub>1c</sub>), higher ambulatory systolic BP (HR 1.28; 95% CI 1.09, 1.50; p = 0.003, for each 1 SD increase in daytime systolic BP [SBP]) and increased aortic stiffness (HR 1.16; 95% CI 1.00, 1.34; p = 0.05) were independent predictors of development or progression of DKD. 29063128 2018
Entrez Id: 54535
Gene Symbol: CCHCR1
CCHCR1
0.020 Biomarker phenotype BEFREE After adjustments for baseline albuminuria and renal function, age, sex, diabetes duration and use of renin-angiotensin antagonists, poorer control of blood glucose (HR 1.17; 95% CI 0.98, 1.40; p = 0.09 for each 1 SD increment in mean first-year HbA<sub>1c</sub>), higher ambulatory systolic BP (HR 1.28; 95% CI 1.09, 1.50; p = 0.003, for each 1 SD increase in daytime systolic BP [SBP]) and increased aortic stiffness (HR 1.16; 95% CI 1.00, 1.34; p = 0.05) were independent predictors of development or progression of DKD. 29063128 2018
Entrez Id: 4982
Gene Symbol: TNFRSF11B
TNFRSF11B
0.010 Biomarker phenotype BEFREE After multivariate analysis, OPG and age remained independently associated with aortic stiffness. 21750158 2012
Entrez Id: 50507
Gene Symbol: NOX4
NOX4
0.010 AlteredExpression phenotype BEFREE Also, NADPH oxidase 4 (NOX4) expression and ROS levels increase with age in aortas, aortic vascular smooth muscle cells (VSMCs) and mitochondria, and are correlated with age-associated aortic stiffness in hypercholesterolemic mice. 31419754 2019
Entrez Id: 197
Gene Symbol: AHSG
AHSG
0.010 GeneticVariation phenotype BEFREE Association of AHSG gene polymorphisms and aortic stiffness in peritoneal dialysis patients. 20453496 2010
Entrez Id: 1506
Gene Symbol: CTRL
CTRL
0.010 Biomarker phenotype BEFREE Carotid but not aortic stiffness was lower in EXP than in CTRL. 28195589 2017
Entrez Id: 4199
Gene Symbol: ME1
ME1
0.010 Biomarker phenotype BEFREE Cocaine Exposure Increases Blood Pressure and Aortic Stiffness via the miR-30c-5p-Malic Enzyme 1-Reactive Oxygen Species Pathway. 29483230 2018
Entrez Id: 1666
Gene Symbol: DECR1
DECR1
0.010 GeneticVariation phenotype BEFREE Common genetic variants of NADPH oxidase do not influence aortic stiffness in young, healthy adults. 22995606 2013
Entrez Id: 10428
Gene Symbol: CFDP1
CFDP1
0.100 GeneticVariation phenotype GWASDB Common genetic variation in the 3'-BCL11B gene desert is associated with carotid-femoral pulse wave velocity and excess cardiovascular disease risk: the AortaGen Consortium. 22068335 2012
Entrez Id: 340895
Gene Symbol: MALRD1
MALRD1
0.100 GeneticVariation phenotype GWASDB Common genetic variation in the 3'-BCL11B gene desert is associated with carotid-femoral pulse wave velocity and excess cardiovascular disease risk: the AortaGen Consortium. 22068335 2012
Entrez Id: 1535
Gene Symbol: CYBA
CYBA
0.010 GeneticVariation phenotype BEFREE Common single nucleotide polymorphisms of the p22phox NADPH oxidase subunit do not influence aortic stiffness in young, healthy adults. 22995606 2013
Entrez Id: 7042
Gene Symbol: TGFB2
TGFB2
0.010 Biomarker phenotype BEFREE Conclusions- IL12p40 depletion promotes the development of abdominal aortic aneurysm, in part, by facilitating recruitment of M2-like macrophages and potentiating aortic stiffness and fibrosis mediated by Tgfβ2. 30580570 2019
Entrez Id: 185
Gene Symbol: AGTR1
AGTR1
0.080 GeneticVariation phenotype BEFREE Conversely, the AGTR1 A 1166C polymorphism was independently associated with aortic stiffness. 8772690 1996